OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hormone Replacement Therapy
Findings advance knowledge in hormone replacement therapy research
July 4th, 2005
Reports from the People's Republic of China, Canada and United States highlight recent research on hormone replacement therapy. Study 1: The phytoestrogen alpha-zearalanol appears to be a "safe estrogen" with less tumorigenic risk, according to a study from China. "Estrogen replacement therapy (ERT) is one of the most challenging issues women and their physicians have to face. Clinical and epidemiological studies have provided conflicting data regarding the cardiovascular benefit versus risk in women using ERT. Although ERT may improve several risk factors of coronary heart disease such as favorable changes in lipid profile, an associated increased...
Source: OBGYN & Reproduction Week (2005-07-04)
|
